-
Mashup Score: 17Artificial intelligence (AI) technologies in Cochrane - 21 day(s) ago
With the recent and rapid advances of AI technologies, and the plethora of new tools available, it can be challenging to know how best to implement these tools without compromising on the quality and integrity of the review. How Cochrane currently uses automation and machine learning in review production. What generative artificial intelligence is, the opportunities it brings and the challenges regarding its safe use. Cochrane’s approach to establishing guidelines for the responsible use of artificial
Source: training.cochrane.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 16Artificial intelligence (AI) technologies in Cochrane - 1 month(s) ago
With the recent and rapid advances of AI technologies, and the plethora of new tools available, it can be challenging to know how best to implement these tools without compromising on the quality and integrity of the review. How Cochrane currently uses automation and machine learning in review production. What generative artificial intelligence is, the opportunities it brings and the challenges regarding its safe use. Cochrane’s approach to establishing guidelines for the responsible use of artificial
Source: training.cochrane.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0What Every CEO Needs To Know About The New AI Act - 2 month(s) ago
The Artificial Intelligence Act was adopted by the EU Parliament on March 13 and is expected to soon become law when it is passed by the European Council.
Source: www.forbes.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Non‐radiologist perception of the use of artificial intelligence (AI) in diagnostic medical imaging reports - 2 month(s) ago
Introduction Incorporating artificial intelligence (AI) in diagnostic medical imaging reports has the potential to improve efficiency. Although perception of radiologists, radiographers, medical stu…
Source: onlinelibrary.wiley.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Single-lead arrhythmia detection through machine learning: cross-sectional evaluation of a novel algorithm using real-world data - 4 month(s) ago
Background Computer-assisted interpretation of single-lead ECG is the preliminary method for clinicians to flag and further evaluate an arrhythmia of clinical importance for acutely ill patients. Critical scrutiny of novel detection algorithms is lacking, particularly in external real-world data sets. This study’s objective was to evaluate a hybrid machine learning model’s ability to classify eight arrhythmias from a single-lead ECG signal from acutely ill patients. Methods This cross-sectional external retrospective evaluation of a previously trained hybrid machine learning model against an ECG reading team in the setting of home hospital care (acute care delivered at home substituting for traditional hospital care) draws from patients admitted at two hospitals in Boston, Massachusetts, USA between 12 June 2017 and 23 November 2019. We calculated classifier statistics for each arrhythmia, all arrhythmias and strips where the model identified normal sinus rhythm. Results The model anal
Source: openheart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7Nvidia Looks to Genentech for Its Next Leap in AI Drug Discovery - 5 month(s) ago
Nvidia has expanded in artificial intelligence (AI)-based life sciences through a new AI drug discovery collaboration with Roche’s Genentech subsidiary.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7Nvidia Looks to Genentech for Its Next Leap in AI Drug Discovery - 6 month(s) ago
Nvidia has expanded in artificial intelligence (AI)-based life sciences through a new AI drug discovery collaboration with Roche’s Genentech subsidiary.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2AI-Created Antibodies Drive Innovation at BigHat Biosciences - 6 month(s) ago
Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed, developed, and perform as therapeutic agents.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2AI-Created Antibodies Drive Innovation at BigHat Biosciences - 6 month(s) ago
Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed, developed, and perform as therapeutic agents.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2AI-Created Antibodies Drive Innovation at BigHat Biosciences - 7 month(s) ago
Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed, developed, and perform as therapeutic agents.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
🤖 How can we use #AI without compromising quality and integrity? 💻 📅 On 9th May @AnnaNoelStorr @EllaFlemyng @James_M_Thomas will talk about #ArtificialIntelligence technologies in Cochrane. Open to all! Sign up: https://t.co/a04b3LCo8g @cochranemthds @cochranetrain https://t.co/nSfu3AefO5